Advanced Disease
Showing 1 - 25 of >10,000
NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in Lexington (Immune checkpoint inhibitor, Radiation Therapy)
Recruiting
- Non-small Cell Lung Cancer
- Squamous Cell Carcinoma of the Head and Neck
- Immune checkpoint inhibitor
- Radiation Therapy
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
Nov 10, 2022
Liver Disease Chronic, End Stage Liver DIsease, Cirrhosis Trial in Boston (LiverPAL)
Not yet recruiting
- Liver Disease Chronic
- +4 more
- LiverPAL
-
Boston, MassachusettsMassachusetts General Hospital
Aug 17, 2023
Subthalamic Deep Brain Stimulation in Advanced Parkinson's
Active, not recruiting
- Parkinson Disease
-
Helsinki, FinlandDepartment of Neurology and department of Neurosurgery Helsinki
Oct 18, 2023
Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)
Recruiting
- Breast Cancer
- ARV-471 (PF-07850327)
- +2 more
-
Orange City, FloridaMid Florida Hematology and Oncology Center
Jun 8, 2023
Parkinson's Disease and Parkinsonism Trial in Calgary (Tailored Support Group)
Not yet recruiting
- Parkinson's Disease and Parkinsonism
- Tailored Support Group
-
Calgary, Alberta, CanadaHealth Science Centre, University of Calgary
Oct 10, 2023
Subcutaneous Infusion of ABBV-951 to Assess Change in Disease
Not yet recruiting
- Parkinson's Disease (PD)
- (no location specified)
Jun 15, 2023
Cirrhosis, Liver, End Stage Liver DIsease, Symptoms and Signs Trial in Philadelphia (LiverWatch Intervention)
Not yet recruiting
- Cirrhosis, Liver
- +4 more
- LiverWatch Intervention
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 13, 2023
Obesity, Interstitial Lung Disease, COPD Trial (Semaglutide Pen Injector)
Not yet recruiting
- Obesity
- +4 more
- Semaglutide Pen Injector
- (no location specified)
Feb 15, 2023
Parkinson Disease Trial in Hangzhou (KL002 injection solution)
Not yet recruiting
- Parkinson Disease
- KL002 injection solution
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital of Zhejiang University School of Medi
May 22, 2023
Pancreatic Cancer, Advanced Cancer, Metastatic Cancer Trial in Beijing (Later-line therapy)
Recruiting
- Pancreatic Cancer
- +2 more
- Later-line therapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Apr 10, 2023
Advanced Nursing Practice on Follow-up of End Stage Chronic
Completed
- Renal Disease
- Collected of Datas
- semi-structured interview
-
Roanne, FranceCH de Roanne
Sep 12, 2023
AADC/TDC in Advanced Parkinson's Disease
Not yet recruiting
- Parkinson Disease
- (no location specified)
Dec 9, 2022
Parkinson Disease Trial (Vibrotactile coordinated reset)
Not yet recruiting
- Parkinson Disease
- Vibrotactile coordinated reset
-
Stanford, CaliforniaStanford University
Dec 5, 2022
Parkinson Disease Trial in Jinan (STN-DBS)
Completed
- Parkinson Disease
- STN-DBS
-
Jinan, Sichuan, ChinaChao Zhang
Oct 15, 2023
Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial (Artificial Intelligence)
Not yet recruiting
- Ovarian Cancer Stage III
- Ovarian Cancer Stage IV
- Artificial Intelligence
- (no location specified)
Aug 24, 2023
HIV Disease Progression Trial (Azithromycin Oral Tablet, Placebo oral tablet)
Not yet recruiting
- HIV Disease Progression
- Azithromycin Oral Tablet
- Placebo oral tablet
- (no location specified)
Oct 13, 2022
Cirrhosis Trial in Rochester (ACE (AI-Cirrhosis-ECG) 2.0)
Not yet recruiting
- Cirrhosis
- ACE (AI-Cirrhosis-ECG) 2.0
-
Rochester, MinnesotaMayo Clinic Minnesota
Mar 12, 2023
Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Trial (Monalizumab, Cetuximab)
Not yet recruiting
- Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
- Monalizumab
- Cetuximab
- (no location specified)
Jan 8, 2023
Stellate Ganglion, Parkinson Disease Trial in Guangzhou (Treatment (Stellate ganglion block;Oral standard anti-Parkinson's
Recruiting
- Stellate Ganglion
- Parkinson Disease
- Treatment （Stellate ganglion block；Oral standard anti-Parkinson's drugs）
- Treatment （Oral standard anti-Parkinson's drugs）
-
Guangzhou, Guangdong, ChinaZhujiang Hospiatal
Oct 26, 2023
COPD Severe Trial (Decision Support Intervention, Health Coaching)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease Severe
- Decision Support Intervention
- Health Coaching
- (no location specified)
Aug 25, 2023
Pancreatic Cancer, Locally Advanced Trial in Beijing (Later-line therapy)
Recruiting
- Pancreatic Cancer
- Locally Advanced
- Later-line therapy
-
Beijing, ChinaDepartment of Medical Oncology, Peking Union Medical College Hos
Apr 10, 2023
Risk Factors for Advanced Fibrosis Among FLD Patients
Not yet recruiting
- NAFLD
- +2 more
- Follow-up
- (no location specified)
Aug 1, 2023
to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally
Recruiting
- to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
- Capecitabine 500Mg Oral Tablet
-
Shanghai, ChinaEye & ENT Hospital, Fudan University
Jul 2, 2023
Parkinson's Disease Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Convection enhanced
Completed
- Parkinson's Disease
- Convection enhanced delivery/AAV2-GDNF
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023